Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Tapan M. Kadia"'
Autor:
Tapan M. Kadia, Guillermo Garcia Manero, Nitin Jain, Naval Daver, Naveen Pemmaraju, Courtney D. DiNardo, G. Borthakur, Hagop M. Kantarjian, Jorge E. Cortes, Farhad Ravandi, Craig Adam
Publikováno v:
Cancer Research. 74:CT307-CT307
Background: Vosaroxin (formerly voreloxin), is a quinolone derived DNA topoisomerase II inhibitor, which is not a substrate for p53 or P-glycoprotein and has limited toxicity; it is currently under evaluation for the treatment of pts with AML and hig